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Fungal rhinosinusitis encompasses a wide spectrum of fun-
gal infections ranging from mildly symptomatic to rapidly
fatal. Fungal colonization of the upper and lower airways is
a common condition secondary to the ubiquitous presence
of fungal spores in the air. Aspergillus species are the most
prevalent colonizers of the sinuses.1 However, colonization
is distinct from infection as the majority of colonized patients
do not become ill with fungal infections. It is the interplay of
the organism with the host’s immune system or lack thereof
that results in the various manifestations of disease. Infec-
tions are distinguished by whether they are invasive and non-
invasive. Based upon the International Society for Human and
Mycology Group (2008), invasive fungal rhinosinusitis is clas-
sified as acute, chronic, or granulomatous.2 The non-invasive
forms of fungal sinusitis are allergic fungal rhinosinusitis and
the fungus ball (fungal mycetoma) (Table 1).Acute fulminant invasive fungal sinusitis
Acute fulminant invasive fungal sinusitis (AFIFS) occurs
predominantly in patients with profound immunosuppres-
sion.3–5 Rarely, it has been reported in otherwise healthyPeer review under responsibility
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by invasion of the blood vessels with resulting tissue infarc-
tion. Unlike the other forms of fungal rhinosinusitis, anatomic
abnormalities that cause sinus pooling, such as nasal polyps
or chronic inflammatory states, do not appear to be signifi-
cant risk factors for AFIFS.4
AFIFS is usually due to Aspergillus species or fungi from
the class Zygomycetes, including Rhizopus, Rhizomucor, Ab-
sidia, and Mucor.7 In diabetic patients, roughly 80% of AFIFS
is secondary to species from the class Zygomycetes; in neu-
tropenic patients, 80% of AFIFS is secondary to Aspergillus
species.6,8 As with all forms of fungal rhinosinusitis, AFIFS be-
gins in the nose and paranasal sinuses after the inhalation of
fungal spores.9 After germination, hypha invade arteries
and cause tissue necrosis by forming fungal thrombi and a fi-
brin reaction, resulting grossly in a ‘‘dry’’ gangrene appear-
ance.10 Spread to orbital and intracranial structures occurs
through direct vascular invasion and occasionally through
embolic seeding.11 This notion of angioinvasion has been
supported by histopathologic examination with demonstra-
tion of fungal growth along the internal elastic lamina of
blood vessels resulting in dissection away from the media,
as well as hyphal growth into the vessel lumen causing endo-
thelial dysfunction and thrombosis. 12 Examples of direct
extension include invasion to the frontal lobes via theProduction and hosting by Elsevier
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Figure 1. (A) 58 year-old female in diabetic ketoacidosis presents with decreased vision, chemosis, proptosis and ophthalmoplegia on the left side
concerning for AFIFS. (B) Oral exam demonstrates poor dental hygiene and necrosis of the hard palate. (C) Endoscopic exam reveals necrosis of the left
inferior turbinate which was removed during debridement. Tissue culture eventually grew Rhizopus microsporious. (D) Orbital exenteration was
performed in conjunction with nasal and sinus debridement because of significant orbital involvement seen on imaging. Involvement of the ethmoid sinus
air cells can be appreciated through the thin medial wall of the orbit.
Table 1. Characteristic features of Fungal Rhinosinusitis.
Type Organisms IS Features Sinuses
AFIFS Aspergillus; Zygomycetes Yes Rapid angioinvasion with tissue infarction Multiple; unilateral
CIFRS A. fumigatus Zygomycetes Mild Chronic sinusitis with slow tissue invasion Multiple; maxillary less
GIFRS Aspergillus flavus No Enlarging cheek mass or proptosis Multiple
Allergic Many No Pansinus expansion Multiple or all
Fungus Ball Aspergillus fumigatus Mild One sinus with proximal obstruction Maxillary most common
Abbreviations: IS, Immunocompromised State.; A, Aspergillus; AFIFS, acute fulminant invasive fungal sinusitis; CIFRS, chronic invasive fungal rhinosinusitis; GIFRS, granulomatous
invasive fungal rhinosinusitis.
420 I.R. Gorovoy et al.ophthalmic arteries or the cribriform plate, or through the
cavernous sinus via the orbital apex.11 In addition, dissemina-
tion to distant organs has been described.13
Symptoms of the infection are related to tissue invasion.
As the infection spreads from the sinuses into the orbit, sev-
eral clinical findings may manifest. Periorbital edema, ptosis,
ophthalmoplegia, visual loss, proptosis, and intraocular
involvement can all be signs of orbital infection (Fig. 1).4
Decreased mentation is particularly concerning for central
nervous system involvement.
AFIFS is considered the most lethal form of fungal sinusi-
tis, historically with mortality rates of 30–80%.3,14 More re-
cent studies report mortality rates under 20% likely because
of earlier recognition and treatment.15–17 Discrepancy exists
as to whether the mortality rate in diabetic patients is higher
than in non-diabetic patients.17,18 While some would argue
that the reversible nature of the immunocompromised state
of diabetic patients would lend to a more favorable outcome,
it has been suggested that there is a greater prevalence of
long-term complications and death in patients infected withZygomycetes, the fungi class more prevalent in diabetics,
compared to Aspergillus.19
Diagnosis of AFIFS is predicated on histopathologic con-
firmation of fungal invasion of the bone or the sinonasal tis-
sue. However, the diseased tissue may not be accessible by
a bedside biopsy. Imaging is thus critical in helping to estab-
lish the diagnosis and guiding surgical planning for biopsy
and debridement.20 Treatment relies on a combination of
antifungal therapy, surgical debridement of affected tissues,
and reversal of immune status when possible.21 Infection with
Aspergillus necessitates parenteral voriconazole; in mucor-
mycosis, dual therapy with amphotericin B and caspofungin
is the current antifungal standard of care,22 although some
data support the use of posaconazole instead, especially in
patients refractory or intolerant of treatment.23 Biopsy of
the tissue is therefore critical to not only establishing the
diagnosis but also directing appropriate therapy.20,24
One of the more difficult determinations in the manage-
ment of AFIFS is whether there is orbital involvement that
may necessitate exenteration. A recent study by Hargrove
Figure 2. Axial (A) and coronal (B) non-enhanced CT of AFIFS shows opacification of the left ethmoid, left maxillary sinus and left nasal cavity.
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sion for exenteration.18 In light of this, the oculoplastic sur-
geon must understand the imaging characteristics of AFIFS
in order to allow detection of the disease and help guide sur-
gical debridement. A high index of suspicion is necessary, as
early presentations are often subtle or attributed to less seri-
ous pathologies such as acute rhinosinusitis.3 It is recom-
mended that immunocompromised patients with symptoms
of sinusitis undergo early radiographic imaging.Figure 3. Axial non-enhanced CT of AFIFS demonstrates opacification of
the left maxillary sinus with soft tissue inflammation of the premalar
tissues (arrowhead) and of the retroantral fat (arrow).Imaging of AFIFS
Due to the dire nature of the infection and the overlapping
symptoms with common viral or bacterial rhinosinusitis,
imaging is critical for early diagnosis of AFIFS and surgical
planning. AFIFS is most commonly diagnosed and evaluated
by computed tomography (CT) and magnetic resonance
imaging (MR). Osseous changes are best evaluated by CT;
however, soft tissue changes are better delineated on MR.
A recent study of immunocompromised patients with histo-
pathologic confirmation of AFIFS found that MR was more
sensitive and had a higher negative predictive value in
detecting early changes of AFIFS, although the specificity
and negative predictive value were equal to that of CT.25
AFIFS most commonly begins as mucosal inflammation
around the middle turbinate. This initial site of infection
may reflect why the middle turbinate is the most frequent
positive biopsy site, accounting for two-thirds of the cases.20
It generally spreads to the maxillary and ethmoid sinuses, fol-
lowed by the sphenoid sinus. The majority of patients with
AFIFS have multiple sinuses affected, generally with only ipsi-
lateral involvement. Posterior ethmoid air cells or sphenoid
sinus involvement increases the likelihood of intracranial
extension.17 CT characteristics of AFIFS include unilateral si-
nus opacification often with focal bone erosion, soft-tissue
thickening of the sinuses and lateral nasal wall mucosa, and
subtle infiltration of perimaxillary fat26,27 (Fig. 2). The fat infil-
tration may be secondary to edema from vascular congestion
or fungal tissue infiltration.28 It can occur prior to bone
destruction as the fungus spreads via perivascular channels.
The bony erosion best identified on CT occurs compara-
tively late in the disease process and signifies extension
beyond the sinus cavities.29 Hyperattenuation or
hypoattenuation of the mucosal secretions is often seen,
although hyperattenuation is more common in chronic inva-
sive fungal rhinosinusitis (CIFRS). The heterogeneous appear-
ance of these fungal sinus secretions may be related to the
presence of trace metals such as manganese, the elevated
protein and decreased water content of the secretions, thepresence of fungal hypha, or a combination of all of these
features.30 Contrast administration to CT can better demon-
strate changes in the periantral soft tissue and cause
enhancement of adjacent extraocular muscles. Marked, uni-
lateral nasal soft-tissue thickening is the most common early
CT finding, although it is not specific to AFIFS.26 Changes
that are more prominent such as retroantral fat pad inflam-
mation, osseous erosion, and intracranial or orbital extension
are more specific, but are late and less common features
(Fig. 3). Intracranial abscesses, consisting of low density
masses with little or no vasogenic edema, signs of leptomen-
ingitis, and well-defined ring enhancement on CT have also
been reported.31
MR findings include nonenhancing, hypointense turbin-
ates (the ‘‘black turbinate sign’’), sinus opacification, air–fluid
concentration, obliteration of the nasopharyngeal planes,
variable intensity within the sinuses on T1- and T2-weighted
images (more likely hypointense on T2), loss of contrast
enhancement (LoCE) of the sinonasal mucosa and extraocular
muscles, inflammatory changes in the extraocular fat and
muscles, and leptomeningeal enhancement29,32,33 (Fig. 4).
The latter two are more common in advanced disease.25
Occasionally, as in the more chronic forms of invasive sinusi-
tis, intracranial granulomas are also seen. These granulomas
generally are hypointense on T1- and T2-weighted images
without or with only minimal contrast enhancement.30
Figure 4. Coronal T1 MR with gadolinium and fat suppression of AFIFS
shows opacification of left maxillary and ethmoid sinuses with hypoin-
tense middle and inferior turbinates (straight arrow) and loss of contrast
enhancement of the maxillary mucosa (arrowhead) and inferior rectus
muscle (curved arrow).
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soft-tissue findings such as infiltration of the periantral fat
and obliteration of nasopharyngeal tissue planes.32 Unfortu-
nately, very early in the disease process, imaging findings
are likely not distinguishable from those of common rhinosi-
nusitis. The earliest findings that should raise suspicion for
AFIFS are periantral fat infiltration, soft tissue stranding adja-
cent to the sinuses, and nasopharyngeal tissue plane obliter-
ation8,34,35 (Fig. 5). On T1, infiltration of periantral fat willFigure 5. Axial T1 MR with gadolinium and fat suppression of AFIFS
demonstrates enhancement of the retroantral fat (arrow).make this region isointense with unaffected surrounding soft
tissue. Therefore, the fat pads adjacent to the maxillary sinus
and its overlying subcutaneous fat should be carefully scruti-
nized for these subtle findings.
Given that AFIFS organisms have a strong tendency to
proliferate along the blood vessels, it is not surprising that
patients are at risk for signs of vasculopathy such as arteritis
with aneurysm, pseudoaneurysm, vasculitis, superior ophthal-
mic vein occlusion, cavernous sinus thrombosis, carotid dis-
section, arterial narrowing, basilar artery thrombosis, and
other manifestations of infarction.35 The cavernous sinus por-
tion of the internal carotid artery should be carefully scruti-
nized because it is especially at risk for damage. When the
fungus extends intracranially, large vessel infarction with
the associated CT and MR findings is observed, usually in
the frontal lobes. Cavernous sinus thrombosis, heralded by
severe headache, exophthalmos, vision loss, and involvement
of cranial nerves II–VI is best evaluated by computed tomog-
raphy venography (CTV) or magnetic resonance venography
(MRV).
The other MR findings in AFIFS may also derive from ische-
mia via angioinvasion. From this vascular occlusion, the
remaining vessels develop congestion, resulting in spillover
edema, which may accentuate the soft tissue infiltration seen
on MR. Loss of contrast enhancement (LoCE) of the sinonasal
mucosa and rectus muscles may occur because infarction of
the smaller blood vessels limits the spread of gadolinium25
(Figs. 4 and 6). This finding is best evaluated on T1 images.
It has only been recently described in the setting of AFIFS
and has not been reported in acute bacterial rhinosinus-
itis.25,36 Unaffected, healthy extraocular muscles and sinona-
sal mucosa enhance with gadolinium on T1 MR. Clinically,
LoCE appears to correlate with devitalized tissue, which
may be dusky or pale, or in the form of a black eschar.
To summarize the imaging evaluation for AFIFS, evidence
of extrasinus infiltration suggests an invasive form of sinusitis.igure 6. Axial T1 MR with gadolinium and fat suppression of AFIFS
ows opacification of the left maxillary sinus with loss of contrast
nhancement of the sinus wall, premalar tissues (straight arrow), retro-




(arrowhead) which likely correlates to tissue necrosis.
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ous sinus involvement. MR is superior to CT in delineating
soft-tissue contrast resolution, and it may therefore better
demonstrate the subtle early findings of fulminant fungal
invasion. When there is clinical suspicion of AFIFS in immuno-
compromised patients, careful attention should be paid to
the retromaxillary and premalar fat, as any infiltration of this
fat is concerning for AFIFS and may occur before osseous
destruction.igure 8. Coronal T2 MR of sinonasal squamous cell carcinoma shows a
rge mass involving the nasal cavity, bilateral ethmoid sinuses and left
axillary sinus with infiltration into the left orbit.Differential diagnoses based on imaging for AFIFS
The non-fungal differential diagnosis of AFIFS includes
complicated acute and chronic viral or bacterial rhinosinusitis,
granulomatosis with polyangitis (formerly Wegener granulo-
matosis), and malignancies, most commonly sinonasal squa-
mous cell carcinoma, and sinonasal non-Hodgkin
lymphoma.37 The overlapping features of these diseases
are that of sinonasal, mass-like, soft tissue involvement with
variable amounts of bony erosion. Compared to AFIFS, gran-
ulomatosis with polyangitis causes more evidence of bony
erosion and less mass-like soft tissue involvement37 (Fig. 7).
The nasal cavity is generally most prominently involved, often
with septal perforation, although orbit and skull base involve-
ment is possible.
Sinonasal squamous cell carcinoma and non-Hodgkin lym-
phoma occur in immunocompetent patients and demon-
strate a solid mass with osseous destruction. In squamous
cell carcinoma, the mass is more solid-appearing with less
adjacent soft tissue involvement compared to AFIFS
(Fig. 8). Additionally, the maxillary antrum is more commonly
involved in squamous cell carcinoma. The soft tissue mass in
sinonasal non-Hodgkin lymphoma demonstrates T2 hypoin-
tensity, which also can occur in AFIFS. In lymphoma, this T2
hypointensity is likely secondary to the high nucleus to
cytoplasm ratio of this malignancy38; however, soft tissueFigure 7. Coronal non-enhanced CT of granulomatosis with polyangitis
demonstrates a homogenous soft tissue mass extending into the left orbit
with erosive changes of the left nasal cavity, ethmoid and maxillary
sinuses resulting in septal perforation and bony erosion of the maxilla.F
la
minvolvement is less prominent and the mass is more homog-
enous compared to AFIFS. As a rule of thumb, AFIFS can
have more diseased tissue outside the sinuses than within
them, and this finding is not present in paranasal sinus
malignancies.39
Complicated acute rhinosinusitis is more commonly of viral
etiology than bacterial. In comparison to AFIFS, it is less likely
to occur in the setting of immunocompromise or to have an
odontogenic etiology, with less soft tissue involvement and
bone erosion.40 Imaging findings can include air fluid levels,
bubbly secretions, secretions of varying densities depending
on composition, and mucosal thickening that can occlude the
osteomeatal complex.36 The sinuses may also be opacified as
in AFIFS; however, sinus involvement is more likely bilateral
and the heterogeneity of secretions in non-fungal secretions
is less distinct.40
In addition, bone thickening and sclerosis of sinus bones
occurs more commonly in chronic viral or bacterial rhinosinus-
itis. Occasionally, it also occurs in allergic fungal rhinosinus-
itis, however, this is often accompanied by sinus
expansion.39 In chronic viral or bacterial rhinosinusitis, the si-
nuses are of normal size and sometimes decreased in volume,
demonstrating concave wall deformities secondary to osteo-
sclerosis.41 LoCE has never been described in complicated
rhinosinusitis, and instead, inflamed mucosa will enhance if
contrast is administered.25,42 Despite these differences, the
suspicion for AFIFS must be raised in at-risk patients and re-
peated imaging may be necessary to help establish the
diagnosis.Chronic forms of invasive fungal rhinosinusitis
All forms of invasive fungal rhinosinusitis are characterized
by fungal invasion of blood vessels, mucosa, submucosa, and
424 I.R. Gorovoy et al.sinus walls. In comparison to the rapid onset of AFIFS, the
chronic forms of invasive sinusitis occur over several months.
Granulomatous invasive fungal rhinosinusitis (GIFRS) presents
with an enlarging mass in the cheek, orbit, nose, or paranasal
sinuses, and generally occurs in immunocompetent hosts.43
The presenting feature is often proptosis. On histology, a
noncaseating granulomatous reaction with considerable per-
ivascular fibrosis and scant hyphal elements is seen.43 Asper-
gillus flavus is the most commonly isolated agent, and the
presence or absence of precipitating antibodies against A.
flavus correlates with disease progression.44 The disease
has primarily been seen in Sudan, India, Pakistan, and Saudi
Arabia.24
Chronic invasive fungal rhinosinusitis (CIFRS) is a slowly
destructive process that most commonly affects the ethmoid
and sphenoid sinuses, but may involve any sinus. Patients are
often elderly and mildly immunosuppressed, and endure
symptoms of chronic rhinosinusitis such as sinus pain, nasal
discharge, low-grade fever, and intermittent epistaxis.39 Ten-
derness overlying a maxillary sinus with accompanying skin
erythema is often observed on physical exam. CIFRS can be
recurrent and persistent. Untreated patients are at risk for
complications including visual changes, orbital apex syn-
drome from orbital invasion, and neurologic sequelae from
central nervous system involvement.45 As seen in AFIFS, pal-
atal erosions can develop from direct extension from the
maxillary sinuses.
Aspergillus fumigatus is the most common pathogen iso-
lated with greater than 50% culture-positive tissue.46 The
other causative agents include the same organisms that
cause AFIFS, as well as dematiaceous molds such as Bipolaris,
Curvularia, Alternaria, and Pseudallescheria. Some authors
believe that CIFRS has a more dense accumulation of hypha
and a more sparse inflammatory reaction compared to GIFRS
while others consider CIFRS to fall on a spectrum with
GIFRS.2,47 The prognosis and therapy are currently the same,
comprising the removal of affected tissue and systemic anti-
fungals,47 although treatments will likely change as more isFigure 9. Axial CT with contrast of granulomatous invasive fungal
rhinosinusitis demonstrating opacification of the ethmoid sinuses and
fat stranding of the intraconal space of the right orbital apex.learned about these entities. In addition, a pseudotumor-like
syndrome has been described in CIFRS patients who were
erroneously placed on steroid therapy.47
The literature on imaging findings in CIFRS and GIFRS is
limited, and the radiographic differences between these
two entities are also unclear. No distinct imaging features
have been reported for chronic/granulomatous invasive fun-
gal sinusitis; they are described as similar to AFIFS, to the
non-invasive forms of fungal sinusitis, or as a combination
of both48 (Fig. 9). Case reports have also described imaging
findings indistinguishable from a malignancy with invasion of
orbital soft tissue, sinuses, and skull base.47,49
In one case series of 17 patients at a tertiary hospital in In-
dia, chronic and granulomatous invasive fungal sinusitis were
grouped together. Radiographic features included unilateral
involvement of one or two sinuses only, homogenous con-
trast enhancement on CT, lack of sinus expansion, bone ero-
sion localized to the area of extra-sinus extension, and
greater extrasinus versus intrasinus involvement.39 Others
have described a soft tissue mass on CT in CIFRS as hyper-
attenuating with destruction of the sinus walls and invasion
outside of the sinuses.50 Invasion of surrounding structures
as seen in AFIFS has been described with the development
of abscesses in the epidural space or brain parenchyma, lep-
tomeningitis, stroke, cavernous sinus thrombosis, osteomy-
elitis, mycotic aneurysm, and hematogenous dissemination.30Non-invasive fungal sinusitis
The noninvasive forms of fungal sinusitis – the allergic and
fungus ball forms – are defined by the absence of hypha
within the sinonasal mucosa. Allergic fungal rhinosinusitis
(AFRS) is likely the most prevalent form of fungal sinusitis.51
It occurs in younger, healthier individuals as compared to
the other forms of fungal sinusitis. Patients often endure
years of nasal congestion, chronic headaches, and other
symptoms of chronic sinusitis. The development of AFRS is
more common in warm, humid climates where fungal species
are more predominant.2
Patients are often atopic with conditions like asthma and
eczema and may be observed to have eosinophilia and ele-
vated total fungus-specific immunoglobulin E (IgE) concen-
trations.52 AFRS represents a hypersensitivity to the
dematiaceous (pigmented) fungi, including Bipolaris, Curvu-
laria, Alternaria, or the hyaline molds such as Aspergillus
and Fusarium.52,53 Accumulation of viscous eosinophilic mu-
cin causes obstruction of sinus outflow tracts, allowing inflam-
matory mediators to cause gradual sinus expansion and bony
erosion.54 Although the condition is not considered invasive,
when untreated the sinus expansion and bony erosion can
rarely lead to intracranial or orbital extension with the dra-
matic presentation of acute visual loss or gross facial dysmor-
phia.55 Treatment involves restoration of the normal sinus
drainage, extirpation of the allergic mucin, and long-term na-
sal steroids to prevent recurrence. Additionally, antifungals
have not been proven to be beneficial in treatment.56
AFRS is best delineated on noncontrast axial CT with coro-
nal reformats. There is often pansinusitis or bilateral involve-
ment of multiple sinuses, with ethmoid involvement being
the most common8 (Fig. 10). On noncontrast CT, allergic mu-
cin causes hyperintensity and near-complete opacification of
the sinus lumens, whose mucosal linings are hypodense. With
Figure 10. Axial CT of allergic fungal rhinosinusitis shows bilateral
involvement of the ethmoid and sphenoid sinuses filled with hyperintense
mucin and evidence of sinus expansion and bone erosion. (Courtesy of
William Dillon, MD and Songling Liu, MD.)
Fungal rhinosinusitis and imaging modalities 425contrast administration, lack of enhancement in the center or
in majority of the sinus helps distinguish AFRS from malignant
tumors.41 Evidence of sinus expansion and osseous remodel-
ing is also commonly observed. MR is obtained when there is
concern that the process extends into the cranium or orbit.57
A fungus ball, also referred to as a mycetoma, aspergil-
loma, or chronic noninvasive granuloma, is an uncommon
form of fungal sinusitis found in older, largely immunocompe-
tent population. Interestingly, in contrast to the other forms
of fungal rhinosinusitis, which are more common in males,
the fungus ball is more prevalent in females.58 The putative
cause is an inadequate mucociliary clearance system in which
fungal organisms are not cleared from one of the sinuses dis-
tal to a site of obstruction; this may occur after radiation
treatment, sinus surgery, or trauma.59 Patients may be
asymptomatic or have minor chronic sinusitis symptoms such
as nasal discharge, cacosmia, or chronic pressure over one si-
nus.59 Except in cases of extreme immunosuppression, the
fungus does not invade blood vessels, bone, or sinonasal mu-Figure 11. Coronal T2 MR of a fungus ball of the sphenoid sinus
demonstrates low signal intensity (arrow). (Courtesy of William Dillon, MD
and Songling Liu, MD.)cosa, although chronic nongranulomatous inflammation may
be observed in the mucosa. Fungus balls are usually second-
ary to A. fumigatus; however, other fungi such as Pseudalle-
scheria boydii and Alternaria have also been described as the
etiologic agent.60
CT often demonstrates the involvement of only one sinus
with a hyperintense (‘‘metal-dense’’) spot at the center of
the fungus ball, often with sclerosis of the adjacent bone.14
It may be ovoid in shape or assume the contour of the sinus
lumen. The fungus ball demonstrates low signal on both T1
and T2-weighted MR secondary to a lack of free water59
(Fig. 11). Non-enhanced CT is often considered the study
of choice because intralesional calcifications are also often
seen.61 Fungus balls are a surgical entity; antifungals and glu-
cocorticoids are ineffective, and recurrence after removal is
infrequent.1Conclusion
Fungal rhinosinusitis can be noninvasive or invasive. The
different forms of fungal sinusitis can present with overlap-
ping features. However, because of different pathophysiol-
ogy and host immune response, specific imaging findings
can be appreciated. Of the invasive forms, acute fulminant
invasive fungal sinusitis is an especially important clinical en-
tity to the oculoplastic surgeon because early intervention
can be life-saving. Chronic invasive fungal sinusitis and
chronic granulomatous invasive fungal sinusitis develop over
a prolonged time course although they can have extensive
involvement as with AFIFS. Head and neck malignancies
can have similar imaging findings and must be kept in consid-
eration as well.References
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